Food News and Research

RSS

FDA releases statement on urgent nationwide egg recall

Working closely with the Centers for Disease Control and Prevention (CDC) and state public health partners, the FDA reviewed epidemiologic and environmental investigation documents and identified 3 best-case clusters of Salmonella Enteritidis illnesses. Tracebacks revealed Wright County Egg in Iowa as the common shell egg supplier in these clusters.

20 Aug 2010

Knopp Neurosciences enters $345 million worldwide licensing agreement with Biogen Idec

A Pittsburgh start-up company that received an early investment from one of Pennsylvania's most dynamic resources has entered into an exclusive licensing agreement to help find the cure for Lou Gehrig's disease, or ALS, Department of Community and Economic Development Secretary Austin Burke announced today.

20 Aug 2010

Afghanistan, African countries lead global food insecurity list

Afghanistan and nine African countries top a list measuring global food insecurity, which was released on Thursday, Agence France-Presse reports.

20 Aug 2010

Enteric microbiome affects disease susceptibility, provides therapeutic target for food-borne diseases: Research

At any given time, trillions of tiny microbes some helpful, some harmful are living on and in humans, forming communities and outnumbering the body's own cells tenfold. Using a $7.3 million federal grant that establishes a new cooperative research center at Michigan State University, a group of investigators is studying the microbes that live in our intestines, analyzing the role they play in food- and water-borne illnesses that kill millions of people each year worldwide.

20 Aug 2010

FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta

The U.S. Food and Drug Administration (FDA) Anesthetic and Life Support Drugs Advisory Committee voted 8-6 in favor of expanding the pain indications for Eli Lilly and Company's (NYSE: LLY) Cymbalta® (duloxetine HCl) to a broader pain population that will be further defined by the FDA, if approved.

20 Aug 2010

FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has granted a priority review designation to BENLYSTA (belimumab) as a potential treatment for systemic lupus erythematosus.

20 Aug 2010

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.

20 Aug 2010

Cetero Research expands Clinical Dermatology and Transdermal Delivery System services

Cetero Research, the leading early stage contract research organization (CRO), today announced the expansion of multiple Clinical Dermatology and Transdermal Delivery System (TDDS) services to four Cetero clinical facilities.

20 Aug 2010

Gilead receives Notice Letter of Sigmapharm's ANDA submission for generic Hepsera

Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Sigmapharm Laboratories, LLC submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Hepsera® (adefovir dipivoxil).

20 Aug 2010

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.

20 Aug 2010

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.

20 Aug 2010

Trius Therapeutics second quarter 2010 revenue increases to $2.1 million

Trius Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections, announced today its financial results for the three months ended June 30, 2010.

20 Aug 2010

New ways to tackle diabetes

According to a new analysis from UK, a diet rich in green leafy vegetables may reduce the risk of developing diabetes. The inference was drawn from six studies which looked into fruit and vegetable intake and found that only food including spinach and cabbage was found to have a significant positive effect. The findings were published in the British Medical Journal (BMJ).

19 Aug 2010

IR USA increases fundraising goal for Pakistan flood victims to $4M

Islamic Relief USA, a Washington, D.C.-based relief and development organization, today announced that it has increased its fundraising goal for the Pakistan flood victims to $4 million due to the worsening conditions in the region. It has also collected more than $23 million in in-kind donations.

19 Aug 2010

Study quantifies risk for gastrointestinal illness due to E. coli bacteria at inland beach

New research shows a clear link between increasing levels of E. coli bacteria in an inland Ohio lake and a greater risk that swimmers in the water will suffer a gastrointestinal illness.

19 Aug 2010

Concern about slow pace of aid for Pakistan mounts as U.N. secures additional funds

U.N. officials and aid groups "expressed alarm on Tuesday that the plight of millions of Pakistanis flooded from their land has yet to strike a sufficiently sympathetic nerve among donors - neither governments nor the general public - with aid trickling in far more slowly than needed," the New York Times reports.

19 Aug 2010

Humana announces 2010 finalists for Houston charitable grant

Today, health-benefits company Humana announced the three finalists for its 2010 $100,000 Humana Communities Benefit - Houston charitable grant.

19 Aug 2010

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds. The technologies are available for licensing to interested companies and entrepreneurs.

19 Aug 2010

Scientists discover synergistic effect to delay fat digestion

Institute of Food Research scientists have discovered an unexpected synergy that helps break down fat. The discovery provides a focus to find ways to slow down fat digestion, and ultimately to create food structures that induce satiety.

19 Aug 2010

U-M research results show potential for discovering new avenues for anti-aging drugs

A team of University of Michigan scientists has found that suppressing a newly discovered gene lengthens the lifespan of roundworms. Scientists who study aging have long known that significantly restricting food intake makes animals live longer. But the goal is to find less drastic ways to achieve the same effect in humans someday. The U-M results offer promising early evidence that scientists may succeed at finding targets for drugs that someday could allow people to live longer, healthier lives.

19 Aug 2010

Food News and Research

FDA releases statement on urgent nationwide egg recall

Knopp Neurosciences enters $345 million worldwide licensing agreement with Biogen Idec

Afghanistan, African countries lead global food insecurity list

Enteric microbiome affects disease susceptibility, provides therapeutic target for food-borne diseases: Research

FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta

FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Cetero Research expands Clinical Dermatology and Transdermal Delivery System services

Gilead receives Notice Letter of Sigmapharm's ANDA submission for generic Hepsera

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Trius Therapeutics second quarter 2010 revenue increases to $2.1 million

New ways to tackle diabetes

IR USA increases fundraising goal for Pakistan flood victims to $4M

Study quantifies risk for gastrointestinal illness due to E. coli bacteria at inland beach

Concern about slow pace of aid for Pakistan mounts as U.N. secures additional funds

Humana announces 2010 finalists for Houston charitable grant

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Scientists discover synergistic effect to delay fat digestion

U-M research results show potential for discovering new avenues for anti-aging drugs

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News